CIK: 0001637946
Total reported value
$183.6M
Reporting period: 2026-03-31 · Number of holdings: 12
General Catalyst Group Management, LLC disclosed 12 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $183.6M and a quarterly turnover rate of 28.8%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "G"
General Catalyst Group Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.216 — mathematically equivalent to about 5 equally-sized positions, well below its 12 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.32), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 61% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add AVBP
0.0% $4.4M
Trim GTLB
0.0% -$14.6M
Trim GUTS
0.0% -$8.5M
Add IOT
0.0% -$7.5M
Trim MAZE
0.0% -$12.0M
Add CART
0.0% -$5.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IOT | Samsara Inc-cl A | Stock-Tech | 34.53% | +2.56% | — | |
| 2 | AVBP | Arrivent Biopharma INC | Stock-Other | 18.79% | +5.23% | — | |
| 3 | MAZE | Maze Therapeutics INC | Stock-Other | 16.85% | -2.50% | — | |
| 4 | CART | Maplebear INC | Stock-Consumer Disc | 14.50% | +0.08% | — | |
| 5 | GTLB | Gitlab Inc-cl A | Stock-Tech | 10.86% | -4.73% | — | |
| 6 | EIKN | Eikon Therapeutics INC | Stock-Other | 1.76% | +1.76% | NEW | |
| 7 | GUTS | Fractyl Health INC | Stock-Other | 1.22% | -3.63% | — | |
| 8 | LIFE | Ethos Technologies INC Cl-a | Stock-Other | 0.45% | +0.45% | NEW | |
| 9 | CPNG | Coupang INC | Stock-Consumer Disc | 0.38% | +0.38% | NEW | |
| 10 | AMZN | Amazon.com INC | Stock-Consumer Disc | 0.29% | +0.29% | NEW | |
| 11 | META | Meta Platforms Inc-class A | Stock-Comm Services | 0.21% | +0.21% | NEW | |
| 12 | FIG | Figma Inc-cl A | Stock-Other | 0.17% | -0.08% | — |
Performance for Q3 2026
+13.3%
Performance Last 4 Quarters
-30.4%
Based on 65% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 12 | $183.6M | 29 | |
| 2025-12-31 | 7 | $221.7M | 100 | |
| 2025-09-30 | 8 | $3.0B | 82 | |
| 2025-06-30 | 10 | $4.3B | 0 | |
| 2025-03-31 | 11 | $887.5M | 100 | |
| 2024-12-31 | 11 | $1.1B | 0 | |
| 2024-09-30 | 11 | $1.4B | 0 | |
| 2024-06-30 | 11 | $1.2B | 0 | |
| 2024-03-31 | 11 | $1.3B | 0 | |
| 2023-12-31 | 10 | $1.3B | 0 | |
| 2023-09-30 | 11 | $1.1B | 0 | |
| 2023-06-30 | 10 | $1.2B | 0 | |
| 2023-03-31 | 10 | $965.0M | 0 | |
| 2022-12-31 | 12 | $889.0M | 0 | |
| 2022-09-30 | 15 | $1.1B | 0 | |
| 2022-06-30 | 15 | $1.1B | 0 | |
| 2022-03-31 | 15 | $1.8B | 0 | |
| 2021-12-31 | 13 | $2.6B | 0 | |
| 2021-09-30 | 12 | $2.0B | 0 | |
| 2021-06-30 | 10 | $2.3B | 29 | |
| 2021-03-31 | 7 | $2.6B | 45 | |
| 2020-12-31 | 5 | $2.9B | 100 | |
| 2018-09-30 | 2 | $28.6M | 19 | |
| 2018-06-30 | 2 | $34.3M | 100 | |
| 2018-03-31 | 1 | $12.6M | 7 | |
| 2017-12-31 | 1 | $13.5M | 0 |
General Catalyst Group Management, LLC's most significant position changes for 2026-03-31: New buy: Eikon Therapeutics INC (EIKN); New buy: Ethos Technologies INC Cl-a (LIFE); New buy: Coupang INC (CPNG); New buy: Amazon.com INC (AMZN); New buy: Meta Platforms Inc-class A (META).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AVBP | Arrivent Biopharma INC | +5.2% | — | Unchanged |
| 2 | IOT | Samsara Inc-cl A | +2.6% | — | Unchanged |
| 3 | CART | Maplebear INC | +0.1% | — | Unchanged |
| 4 | FIG | Figma Inc-cl A | -0.1% | — | Unchanged |
| 5 | MAZE | Maze Therapeutics INC | -2.5% | — | Unchanged |
| 6 | GUTS | Fractyl Health INC | -3.6% | — | Unchanged |
| 7 | GTLB | Gitlab Inc-cl A | -4.7% | — | Unchanged |
| 8 | EIKN | Eikon Therapeutics INC | — | NEW | New buy |
| 9 | LIFE | Ethos Technologies INC Cl-a | — | NEW | New buy |
| 10 | CPNG | Coupang INC | — | NEW | New buy |
| 11 | AMZN | Amazon.com INC | — | NEW | New buy |
| 12 | META | Meta Platforms Inc-class A | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-04-16 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-01-23 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-06 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-10 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-09 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-09 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-08 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-04-14 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-15 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-09 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-07-29 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-05 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-03 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-04-25 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001802098
Total reported value
$183.6M
81 stks
2021-03-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001986795
Total reported value
$183.6M
56 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001719203
Total reported value
$183.5M
37 stks
2023-03-31
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000908551
Total reported value
$11.8B
3 stks
2026-03-31
1 of the top 5 holdings overlap, including Samsara Inc-cl A
CIK 0001274403
Total reported value
$677.1M
10 stks
2026-03-31
1 of the top 5 holdings overlap, including Maze Therapeutics INC
CIK 0001362255
Total reported value
$912.9M
29 stks
2026-03-31
1 of the top 5 holdings overlap, including Maplebear INC